Accuronix Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $625K
Latest Deal Amount
  • Investors
  • 2

Accuronix Therapeutics General Information

Description

Developer of novel therapies designed to solve the most difficult problems in cancer therapy. The company's therapies are based on technology that selectively targets Sigma-2 receptors overexpressed on cancer cells, enabling doctors to increase efficacy and reduce toxicity risk.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 4340 Duncan Avenue
  • Suite 210
  • Saint Louis, MO 63110
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Accuronix Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 28-Jan-2016 $625K 00000 Completed Startup
1. Early Stage VC 0000 0000 Completed Startup
To view Accuronix Therapeutics’s complete valuation and funding history, request access »

Accuronix Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of novel therapies designed to solve the most difficult problems in cancer therapy. The company's therapies ar
Biotechnology
Saint Louis, MO
00000
0000000000 0 00000

0000000

aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea com
0000 000000000
Schlieren, Switzerland
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00

00000000

por incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Accuronix Therapeutics Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ImmunOs Therapeutics Venture Capital-Backed Schlieren, Switzerland 00 000.00 00000000000 000.00
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000 0000000000 Venture Capital-Backed Bozeman, MT 000.00 0000000000 000.00
000000 00000000000 Formerly VC-backed Watertown, MA 00 00000 00000000 00000
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
You’re viewing 5 of 16 competitors. Get the full list »

Accuronix Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Bradley Keller Ph.D Co-Chief Executive Officer & President
Dennis Schafer Co-Chief Executive Officer & President
Robert Mach Ph.D Co-Founder
William Hawkins MD Co-Founder
Linda Law Vice President
To view Accuronix Therapeutics’s complete executive team members history, request access »

Accuronix Therapeutics Board Members (1)

Name Representing Role Since
Charles Bolten BioGenerator Board Member 000 0000
To view Accuronix Therapeutics’s complete board members history, request access »

Accuronix Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioGenerator Venture Capital Minority 000 0000 000000 0
Missouri Technology Corporation Venture Capital Minority 000 0000 000000 0
To view Accuronix Therapeutics’s complete investors history, request access »